Oramed Pharmaceuticals Ownership | Who Owns Oramed Pharmaceuticals?

Oramed Pharmaceuticals Ownership Summary

Oramed Pharmaceuticals is owned by 17.21% institutional investors, 10.62% insiders, and 72.17% retail investors. Murchinson is the largest institutional shareholder, holding 4.20% of ORMP shares. iShares Micro-Cap ETF is the top mutual fund, with 0.21% of its assets in Oramed Pharmaceuticals shares.

ORMP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Oramed Pharmaceuticals	17.21%	10.62%	72.17%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Murchinson	1.70M	4.20%	$4.37M
Bml capital management	1.35M	3.34%	$3.47M
Boothbay fund management	825.00K	2.04%	$2.12M
Rathbones group	289.80K	0.72%	$744.79K
Two sigma advisers, lp	259.10K	0.64%	$665.89K
Renaissance	230.80K	0.57%	$593.16K
Bank of america corp /de/	173.24K	0.43%	$445.23K
Two sigma investments, lp	150.37K	0.37%	$386.44K
Susquehanna group, llp	125.83K	0.31%	$323.38K
Blackrock	89.71K	0.22%	$230.54K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bml capital management	1.35M	2.47%	$3.47M
Murchinson	1.70M	0.67%	$4.37M
Boothbay fund management	825.00K	0.05%	$2.12M
Sage capital management	16.75K	0.02%	$43.05K
Savvy advisors	18.81K	0.02%	$48.34K
Glass jacobson investment advisors	10.54K	0.01%	$27.09K
Rathbones group	289.80K	0.00%	$744.79K
N.e.w. advisory services	12.36K	0.00%	$31.77K
Xtx topco	15.47K	0.00%	$39.77K
Virtu financial	14.78K	0.00%	$38.00K

Top Buyers

Holder	Shares	% Assets	Change
Bml capital management	1.35M	2.47%	504.54K
Murchinson	1.70M	0.67%	320.50K
Boothbay fund management	825.00K	0.05%	135.25K
Renaissance	230.80K	0.00%	108.70K
Millennium management	19.46K	-	19.46K

Top Sellers

Holder	Shares	% Assets	Change
Susquehanna group, llp	125.83K	0.00%	-218.61K
Bank of america corp /de/	173.24K	-	-113.81K
D. e. shaw	38.57K	0.00%	-31.94K
Jane street group	56.07K	-	-30.35K
Oxford asset management llp	-	-	-10.07K

New Positions

Holder	Shares	% Assets	Change	Value
Millennium management	19.46K	-	19.46K	$50.00K
Atria investments	16.61K	0.00%	16.61K	$42.69K
Russell investments group	250.00	-	250.00	$643.00

Sold Out

Holder	Change
Innealta capital	-13.00
Mather group, llc.	-100.00
Global retirement partners	-100.00
Qube research	-107.00
Tyler-stone wealth management	-300.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	56	-3.45%	6,959,416	17.28%	17	7.99%	22	-	14	-
Jun 30, 2024	58	9.43%	5,933,790	12.77%	14	8.67%	22	4.76%	14	-
Mar 31, 2024	53	-10.17%	5,261,693	2.01%	13	8.00%	21	-19.23%	14	27.27%
Dec 31, 2023	59	1.72%	5,157,843	124.71%	12	39.17%	26	-3.70%	11	-15.38%
Sep 30, 2023	58	9.43%	2,295,285	0.82%	5	17.65%	27	17.39%	13	-18.75%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Micro-Cap ETF	84.64K	0.21%	-
SPDR® Portfolio Developed Wld ex-US ETF	47.51K	0.12%	-
MTF TR TA-Growth	29.60K	0.07%	-2.73K
I.B.I 70/30	26.00K	0.06%	-
Fidelity Nasdaq Composite Index	25.45K	0.06%	-
Dimensional US Core Equity 2 ETF	21.73K	0.05%	-
Avantis US Small Cap Equity ETF	15.44K	0.04%	-
SPDR® S&P® International Small Cap ETF	12.42K	0.03%	-
IBI Mehaka TA-Growth	8.84K	0.02%	71.00
AJO Vista US Micro Cap Equity	8.39K	0.02%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 03, 2023	Mayer Arie	-	Buy	$11.12K
Apr 04, 2023	Mayer Arie	-	Buy	$8.40K
Mar 16, 2023	KIDRON NADAV	President and CEO	Buy	$53.01K
Mar 14, 2023	KIDRON NADAV	President and CEO	Buy	$201.00K
Mar 14, 2023	Kidron Miriam	Chief Scientific Officer	Sell	$201.00K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q2	2	-
2023 Q1	4	3

ORMP Ownership FAQ

Who Owns Oramed Pharmaceuticals?

Oramed Pharmaceuticals shareholders are primarily institutional investors at 17.21%, followed by 10.62% insiders and 72.17% retail investors. The average institutional ownership in Oramed Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Oramed Pharmaceuticals falls below.

Who owns the most shares of Oramed Pharmaceuticals?

Oramed Pharmaceuticals’s largest shareholders are Murchinson (1.7M shares, 4.20%), Bml capital management (1.35M shares, 3.34%), and Boothbay fund management (825K shares, 2.04%). Together, they hold 9.58% of Oramed Pharmaceuticals’s total shares outstanding.

Does Blackrock own Oramed Pharmaceuticals?

Yes, BlackRock owns 0.22% of Oramed Pharmaceuticals, totaling 89.71K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 230.54K$. In the last quarter, BlackRock increased its holdings by 411 shares, a 0.46% change.

Who is Oramed Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is Oramed Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.47% of its assets in 1.35M Oramed Pharmaceuticals shares, valued at 3.47M$.

Who is the top mutual fund holder of Oramed Pharmaceuticals shares?

iShares Micro-Cap ETF is the top mutual fund holder of Oramed Pharmaceuticals shares, with 0.21% of its total shares outstanding invested in 84.64K Oramed Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools